RMDI
VRTX icon

R.M. Davis Inc’s Vertex Pharmaceuticals VRTX Stock Holding History

R.M. Davis Inc’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$557K Hold
1,121
– – 0.01% 202
2026
Q1 		$501K Sell
1,121
-14
-1% -$6.53K 0.01% 195
2025
Q4 		$514K Buy
1,135
+360
+46% +$155K 0.01% 199
2025
Q3 		$303K Sell
775
-360
-32% -$150K 0.01% 234
2025
Q2 		$505K Buy
1,135
+4
+0.4% +$1.84K 0.01% 202
2025
Q1 		$548K Buy
1,131
+86
+8% +$40.1K 0.01% 193
2024
Q4 		$421K Buy
1,045
+205
+24% +$95K 0.01% 215
2024
Q3 		$391K Buy
840
+10
+1% +$4.8K 0.01% 217
2024
Q2 		$389K Buy
830
+333
+67% +$145K 0.01% 219
2024
Q1 		$208K Buy
497
+5
+1% +$2.11K ﹤0.01% 254
2023
Q4 		$200K Buy
+492
New +$182K ﹤0.01% 261

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

R.M. Davis Inc's VRTX Position: Q2 2026 in Review

R.M. Davis Inc held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 1,121 shares worth $557K. The position accounts for 0.01% of the portfolio, ranked #202.

R.M. Davis Inc first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • R.M. Davis Inc held 1,121 shares of Vertex Pharmaceuticals worth $557K as of Q2 2026.
  • R.M. Davis Inc left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.01% of R.M. Davis Inc's portfolio in Q2 2026, its #202 holding.
  • R.M. Davis Inc first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on R.M. Davis Inc's 13F filing for Q2 2026, filed 14 Aug 2026.